SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001117480-23-000028
Filing Date
2023-11-02
Accepted
2023-11-02 08:22:23
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmrx-20230930.htm   iXBRL 10-Q 1365497
2 EX-31.1 a20230930cmrxex-311.htm EX-31.1 9518
3 EX-32.1 a20230930cmrxex-321.htm EX-32.1 7037
  Complete submission text file 0001117480-23-000028.txt   6086987

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmrx-20230930.xsd EX-101.SCH 40409
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cmrx-20230930_cal.xml EX-101.CAL 63510
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmrx-20230930_def.xml EX-101.DEF 193173
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmrx-20230930_lab.xml EX-101.LAB 477180
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmrx-20230930_pre.xml EX-101.PRE 322016
54 EXTRACTED XBRL INSTANCE DOCUMENT cmrx-20230930_htm.xml XML 803359
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

IRS No.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35867 | Film No.: 231370228
SIC: 2834 Pharmaceutical Preparations